WEST PHARMACEUTICAL SERVICES, INC. West Pharmaceutical Services, Inc. Stock
Equities
WST
US9553061055
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 372 USD | -1.40% |
|
-2.09% | +5.66% |
Financials (USD)
| Sales 2024 * | 3.01B | Sales 2025 * | 3.29B | Capitalization | 27.62B |
|---|---|---|---|---|---|
| Net income 2024 * | 566M | Net income 2025 * | 676M | EV / Sales 2024 * | 8.92 x |
| Net cash position 2024 * | 761M | Net cash position 2025 * | 1.4B | EV / Sales 2025 * | 7.98 x |
| P/E ratio 2024 * |
49.9
x | P/E ratio 2025 * |
42
x | Employees | 10,600 |
| Yield 2024 * |
0.26% | Yield 2025 * |
0.29% | Free-Float | 97.05% |
More Fundamentals
* Assessed data
More news
Latest transcript on West Pharmaceutical Services, Inc.
More recommendations
More news
| 1 day | -1.40% | ||
| 1 week | -1.79% | ||
| Current month | -5.98% | ||
| 1 month | -5.60% | ||
| 3 months | +7.18% | ||
| 6 months | +2.30% | ||
| Current year | +5.66% |
1 week
371.88
386.56
1 month
371.88400.88
Current year
325.74413.70
1 year
310.42415.73
3 years
206.19475.35
5 years
110.14475.35
10 years
39.11475.35
| Managers | Title | Age | Since |
|---|---|---|---|
Eric Green
CEO | Chief Executive Officer | 55 | 15-04-23 |
Bernard Birkett
DFI | Director of Finance/CFO | 55 | 18-06-20 |
Silji Abraham
CTO | Chief Tech/Sci/R&D Officer | 52 | 18-02-25 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 66 | 11-01-31 | |
Eric Green
CEO | Chief Executive Officer | 55 | 15-04-23 |
Paolo Pucci
BRD | Director/Board Member | 63 | 16-09-11 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.04% | 5 M€ | -1.80% | - | |
| 1.44% | 16 M€ | -9.75% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 372 | -1.40% | 444,710 |
| 24-04-18 | 377.3 | -0.01% | 315,059 |
| 24-04-17 | 377.4 | -0.56% | 355,424 |
| 24-04-16 | 379.5 | +0.18% | 491,817 |
| 24-04-15 | 378.8 | -0.31% | 284,540 |
Delayed Quote Nyse, April 19, 2024 at 04:00 pm EDT
More quotes
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows:
- own manufactured products (81.8%);
- products manufactured under contract (18.2%).
Net sales are distributed geographically as follows: the United States (42.3%), Germany (16.8%), Ireland (8.7%), France (7.5%), Europe (12.1%) and other (12.6%).
Calendar
2024-04-22
- Ex-dividend day
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
377.3
USD
Average target price
390.6
USD
Spread / Average Target
+3.51%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +5.66% | 27.62B | |
| -2.53% | 183B | |
| -3.52% | 105B | |
| +5.33% | 51.77B | |
| +16.43% | 47.29B | |
| -1.73% | 40.2B | |
| -2.01% | 25.51B | |
| +9.84% | 24.73B | |
| -1.87% | 24.52B | |
| +9.12% | 22.68B |
- Stock Market
- Equities
- WST Stock
